Welcome to Tianjin Medical University Cancer Institute & Hospital!
Tianjin Medical University Cancer Institute & Hospital (TMUCIH) is one of the largest specialized hospitals in China with integrated patient care, education, training, research and preventative medicine with 2319 beds, 46 clinical and diagnostic departments and 13 basic research departments. In 2013, TMUCIH was designated as National Clinical Research Center for Cancer by the Ministry of Science and Technology of The People’s Republic of China. In 2017, Oncology was ranked as the National “World-Class” Academic Development by The Ministry of Education, the Ministry of Finance, and the National Development and Reform Commission.
The most recognized specialties in the hospital are basic and clinical research on breast cancer, lung cancer, esophageal cancer, head & neck Cancer, biotherapy, molecular imaging, radiation oncology, medical oncology, pathology as well as epidemiology. TMUCIH launched “Advanced National Oncologists and pathologists training course” commissioned by the Ministry of Health since 1954. TMUCIH issued the first cancer journal “Chinese Journal of Clinical Oncology (CJCO)”, which is one of the major state level journals, in 1963. The English edition of CJCO “Cancer Biology & Medicine” was launched in 2004, according to the Journal Citation Reports (2018), the first impact factor (2017) of Cancer Biology & Medicine is 4.607.
Our hospital strives for excellence, strict management and first class service to fulfill our hospital motto of “Providing patients with uttermost integrity and state-of-art medicine and improving our profession with ingenuity and innovation”. The hospital has won special honors, such as National Civilization Unite; Health Circle National Advanced Unite ; and Young Civilized Institution authorized by Ministry of Health.
We are confident that we will offer the best treatment and care for cancer patients through promoting cancer research, treatment, and education.